Page 215 - Williams Hematology ( PDFDrive )

190 Part IV: Molecular and Cellular Hematology <CN>: <CT> PB

79. Lenz G, Wright GW, Emre NC, et al: Molecular subtypes of diffuse large B-cell lym- 85. Starostik P, Patzner J, Greiner A, et al: Gastric marginal zone B-cell lymphomas of
phoma arise by distinct genetic pathways. Proc Natl Acad Sci U S A 105:13520–13525, MALT type develop along 2 distinct pathogenetic pathways. Blood 99:3–9, 2002.
2008. 86. Chiarle R, Voena C, Ambrogio C, et al: The anaplastic lymphoma kinase in the patho-
80. Haralambieva E, Boerma EJ, van Imhoff GW, et al: Clinical, immunophenotypic, and genesis of cancer. Nat Rev Cancer 8:11–23, 2008.
genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma. 87. Shaughnessy JD Jr, Zhan F, Burington BE, et al: A validated gene expression model of
Am J Surg Pathol 29:1086–1094, 2005. high-risk multiple myeloma is defined by deregulated expression of genes mapping to
81. Viardot A, Barth TF, Moller P, et al: Cytogenetic evolution of follicular lymphoma. chromosome 1. Blood 109:2276–2284, 2007.
Semin Cancer Biol 13:183–190, 2003. 88. Avet-Loiseau H, Li C, Magrangeas F, et al: Prognostic significance of copy-number
82. Bertoni F, Zucca E, Cotter FE: Molecular basis of mantle cell lymphoma. Br J Haematol alterations in multiple myeloma. J Clin Oncol 27:4585–4590, 2009.
124:130–140, 2004. 89. Rasmussen T, Kuehl M, Lodahl M, et al: Possible roles for activating RAS mutations in
83. Chng WJ, Glebov O, Bergsagel PL, et al: Genetic events in the pathogenesis of multiple the MGUS to MM transition and in the intramedullary to extramedullary transition in
myeloma. Best Pract Res Clin Haematol 20:571–596, 2007. some plasma cell tumors. Blood 105:317–323, 2005.
84. Pasqualucci L, Migliazza A, Basso K, et al: Mutations of the BCL6 proto-oncogene dis-
rupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 101:2914–2923,
2003.

Kaushansky_chapter 13_p0173-0190.indd 190 17/09/15 6:33 pm